NCT00796081View on ClinicalTrials.gov

A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

August 31, 2006

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Interventions
DRUG

ER OROS paliperidone, paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00796081 - A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | Biotech Hunter | Biotech Hunter